Safripol (Pty) Ltd
Technical Data Sheet
E 5560
High Density Polyethylene for Compression Moulding Applications
Safrene® E 5560 High Density Polyethylene Resin is Typical Applications
designed for compression moulding applications. Having
excellent mechanical strength, toughness, environmental • Caps and closures for
stress-crack resistance and good processability, it is carbonated and non-carbonated
especially suitable for the production of carbonated soft beverage applications
drink closures.
TEST
PROPERTIES(1) VALUE UNIT
METHOD
Physical
Melt Flow Rate, 190 °C/ 5 kg 1.5 g/10min ISO 1133
Melt Flow Rate, 190 °C/ 2.16 kg 0.3 g/10min ISO 1133
Density(2) 0.957 g/cm3 ISO 1183
Mechanical (3)
Tensile Yield(4) 28 MPa ISO 527
Flexural Modulus 1450 MPa ISO 178
Environmental Stress-Crack Resistance(5) 150 hours ASTM D1693
Impact (3)
Charpy Notched Impact Strength (23 °C) 12 kJ/m2 ISO 179
Thermal
Vicat Softening Point (10N) 128 °C ISO 306/A50
Vicat Softening Point (50N) 78 °C ISO 306/B50
Crystalline Melting Point 133 °C ISO 3146
(1) Typical values; not to be construed as specification limits. (3) Compression moulded samples
(2) Unannealed (4) Test speed 50 mm/min
(5) Bell test condition B, 50°C, 10% Igepal, F50
Typical processing Compression
conditions Moulding
Feed Zone (°C) 160 - 170
Zone1 (°C) 170 - 180
Zone 2 (°C) 170 - 180
Zone 3 (°C 180 - 190
Die (°C) 190 - 200
Melt Temp (°C) 190 - 200
Page 1 of 2 TDS-HDPE-3035
Hardcopies or electronic saved copies of this document are uncontrolled.
Refer to the Safripol website for latest version.
Safripol (Pty) Ltd
Technical Data Sheet
E 5560
High Density Polyethylene for Compression Moulding Applications
Product At Safripol, protecting people and the environment will be a part of everything we do and every decision we make. Each employee
has a primary responsibility in ensuring that our products and operations meet applicable government standards.
Stewardship
Our goal is to eliminate all injuries, prevent adverse environment and health impacts, reduce wastes and emissions and promote
resource conservation at every stage of the life cycle of our products. The success of this rests with each and every individual
involved with Safripol products throughout the life cycle.
Food Contact Safrene® E 5560 High Density Polyethylene Resin should comply with Commission Regulation (EU) No 10/2011 and with U.S. FDA
21 CFR 177.1520(c)3.1c food contact regulations when used unmodified and processed according to good manufacturing practices
Compliance for food contact applications. The purchaser remains responsible for determining whether the use complies with all relevant
regulations.
Customer Safripol strongly encourages its customers to review both their manufacturing processes and their applications of Safripol products
from the standpoint of human health and environmental quality to ensure that Safripol products are not used in ways for which they
Notice are not intended or tested. Safripol personnel are available to answer your questions and to provide reasonable technical support.
Safripol product literature, including safety data sheets, should be consulted prior to use of Safripol products. Current safety data
sheets are available from Safripol.
Safripol Safripol will not knowingly sell or sample any product or service (“Product”) into any commercial or developmental application that is
intended for:
Medical a. permanent (Long term) contact with internal body fluids or internal body tissues. Long term is a use which exceeds 72
Application continuous hours.
b. use in cardiac prosthetic devices regardless of the length of time involved; (Cardiac prosthetic devices include, but are not
Policy limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic balloons and control systems, and ventricular
bypass assisted devices);
c. use as a critical component in medical devices that support or sustain human life; or
d. use specifically by pregnant women or in applications designed specifically to promote or interfere with human reproduction.
Additionally, all Products intended for use in pharmaceutical applications, other than pharmaceutical packaging, must pass the
current Pharmaceutical Liability Guidelines.
● New business opportunities require a business assessment prior to sale or sampling of Safripol products.
● Authorized distributors and resellers will adhere to this medical policy.
● Safripol does not endorse or claim suitability of their products for specific medical applications. It is the responsibility of the
medical device or pharmaceutical manufacturer to determine that the Safripol product is safe, lawful, and technically suitable for
the intended use. SAFRIPOL MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY
SAFRIPOL PRODUCT FOR USE IN MEDICAL APPLICATIONS.
Disclaimer The Customer is responsible for determining whether products and the information in this document are appropriate for the
Customer’s use and for ensuring that the Customer’s workplace and disposal/ recycling practices of our products and packaging are
in compliance with applicable laws and other governmental enactments. Safripol assumes no obligation or liability for the information
in this document.
NO WARRANTIES ARE GIVEN; ALL IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE ARE EXPRESSLY EXCLUDED.
NOTICE: If products are described as “experimental” or “developmental”: (1) product specifications may not be fully determined; (2)
analysis of hazards and caution in handling and use are required; and (3) there is greater potential for Safripol to change
specifications and/or discontinue production.
Additional Information
Our contact details
Safripol (Pty) Ltd Gauteng:
Private Bag X 52 Tel: +27 (0) 11 575 4549
Bryanston
2021 Kwa-Zulu Natal:
South Africa Tel: +27 (0) 31 450 4111
Published: July 2019
Page 2 of 2 TDS-HDPE-3035
Hardcopies or electronic saved copies of this document are uncontrolled.
Refer to the Safripol website for latest version.
